Wells Fargo analyst Steven Cahall maintained a Buy rating on E. W. Scripps Company Class A (SSP – Research Report) today and set a price target of $20.00. The company’s shares closed last Friday at $14.43.
According to TipRanks, Cahall is an analyst with an average return of -0.7% and a 47.66% success rate. Cahall covers the Services sector, focusing on stocks such as Clear Channel Outdoor, Audacy, and Omnicom Group.
Currently, the analyst consensus on E. W. Scripps Company Class A is a Strong Buy with an average price target of $20.00, which is a 38.60% upside from current levels. In a report released today, Noble Financial also maintained a Buy rating on the stock with a $23.00 price target.
The company has a one-year high of $23.61 and a one-year low of $12.04. Currently, E. W. Scripps Company Class A has an average volume of 295.7K.
Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SSP in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The E.W. Scripps Co. engages in the television and newspaper publishing. It operates through the following business segments: Local Media, National Media, and Others. The Local Media segment is comprised of its local broadcast television stations and their related digital operations. The National Media segment is comprised of the operations of its national media businesses including over-the-air broadcast networks, Katz, its podcast business, Midroll, next generation national news network, Newsy, and other national brands. The company was founded by Edward Willis Scripps in 1878 and is headquartered in Cincinnati, OH.
Read More on SSP:
- Telephone & Data Systems (TDS) Receives a Buy from Raymond James
- Jefferies Keeps Their Buy Rating on Leslie’s (LESL)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: ICU Medical (ICUI), Twist Bioscience (TWST) and Alignment Healthcare (ALHC)
- Credit Suisse Reaffirms Their Hold Rating on TELUS International (CDA) (TIXT)
- Credit Suisse Keeps Their Hold Rating on TripAdvisor (TRIP)